Ionis Pharmaceuticals IncNASDAQ:IONS
- LAST PRICE46.0900
- TODAY'S CHANGE (%)0.4900 (1.0746%)
- Bid / Lots45.1700/ 1
- Ask / Lots46.5000/ 2
- Open / Previous Close45.5400 / 45.6000
- Day Range
- 52 Week Range
- Volume624,741
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IONS |
|---|---|---|
| 09:32 ET | 6355 | 46.04 |
| 09:34 ET | 4264 | 46.035 |
| 09:38 ET | 724 | 45.715 |
| 09:39 ET | 100 | 45.495 |
| 09:43 ET | 200 | 45.57 |
| 09:45 ET | 400 | 45.65 |
| 09:48 ET | 300 | 45.57 |
| 09:50 ET | 1508 | 45.59 |
| 09:52 ET | 3769 | 45.63 |
| 09:54 ET | 750 | 45.605 |
| 09:56 ET | 1946 | 45.55 |
| 09:57 ET | 928 | 45.53 |
| 09:59 ET | 100 | 45.59 |
| 10:01 ET | 1244 | 45.515 |
| 10:03 ET | 100 | 45.5 |
| 10:06 ET | 416 | 45.51 |
| 10:08 ET | 4741 | 45.41 |
| 10:10 ET | 700 | 45.45 |
| 10:12 ET | 1500 | 45.4 |
| 10:14 ET | 200 | 45.4 |
| 10:15 ET | 600 | 45.415 |
| 10:17 ET | 1159 | 45.37 |
| 10:19 ET | 400 | 45.38 |
| 10:21 ET | 800 | 45.415 |
| 10:24 ET | 1527 | 45.405 |
| 10:26 ET | 726 | 45.3948 |
| 10:28 ET | 2771 | 45.49 |
| 10:30 ET | 1625 | 45.49 |
| 10:32 ET | 550 | 45.5 |
| 10:33 ET | 841 | 45.5 |
| 10:35 ET | 4127 | 45.55 |
| 10:37 ET | 609 | 45.39 |
| 10:39 ET | 1645 | 45.54 |
| 10:42 ET | 10932 | 45.47 |
| 10:44 ET | 1913 | 45.54 |
| 10:46 ET | 12158 | 45.555 |
| 10:48 ET | 600 | 45.58 |
| 10:50 ET | 100 | 45.61 |
| 10:51 ET | 400 | 45.63 |
| 10:53 ET | 3522 | 45.54 |
| 10:55 ET | 400 | 45.545 |
| 10:57 ET | 400 | 45.54 |
| 11:00 ET | 1904 | 45.66 |
| 11:02 ET | 1778 | 45.66 |
| 11:04 ET | 200 | 45.69 |
| 11:06 ET | 1087 | 45.82 |
| 11:08 ET | 200 | 45.865 |
| 11:09 ET | 700 | 45.95 |
| 11:11 ET | 352 | 45.94 |
| 11:13 ET | 2176 | 45.89 |
| 11:15 ET | 595 | 45.85 |
| 11:18 ET | 600 | 45.875 |
| 11:20 ET | 13389 | 45.94 |
| 11:22 ET | 1124 | 45.89 |
| 11:24 ET | 946 | 45.82 |
| 11:26 ET | 2033 | 45.915 |
| 11:27 ET | 200 | 45.945 |
| 11:29 ET | 234 | 45.99 |
| 11:31 ET | 1506 | 46.1 |
| 11:33 ET | 1450 | 46.14 |
| 11:36 ET | 1956 | 46.19 |
| 11:38 ET | 200 | 46.165 |
| 11:40 ET | 410 | 46.19 |
| 11:42 ET | 1799 | 46.13 |
| 11:44 ET | 1000 | 46.18 |
| 11:45 ET | 2480 | 46.27 |
| 11:47 ET | 300 | 46.225 |
| 11:49 ET | 446 | 46.225 |
| 11:51 ET | 400 | 46.26 |
| 11:54 ET | 1010 | 46.27 |
| 11:56 ET | 1396 | 46.215 |
| 11:58 ET | 1848 | 46.07 |
| 12:00 ET | 200 | 46.07 |
| 12:02 ET | 2395 | 46.125 |
| 12:03 ET | 1016 | 46.17 |
| 12:05 ET | 700 | 46.21 |
| 12:07 ET | 300 | 46.195 |
| 12:09 ET | 1690 | 46.125 |
| 12:12 ET | 400 | 46.11 |
| 12:14 ET | 600 | 46.15 |
| 12:16 ET | 700 | 46.1 |
| 12:18 ET | 597 | 46.1 |
| 12:20 ET | 900 | 46.06 |
| 12:21 ET | 2533 | 46 |
| 12:23 ET | 307 | 46.015 |
| 12:25 ET | 4235 | 45.94 |
| 12:27 ET | 2910 | 45.925 |
| 12:32 ET | 3000 | 45.91 |
| 12:34 ET | 305 | 45.9 |
| 12:36 ET | 300 | 45.94 |
| 12:38 ET | 2030 | 45.97 |
| 12:39 ET | 2100 | 45.975 |
| 12:41 ET | 1263 | 45.98 |
| 12:43 ET | 600 | 46.01 |
| 12:45 ET | 1721 | 45.985 |
| 12:48 ET | 1180 | 46 |
| 12:50 ET | 400 | 45.93 |
| 12:52 ET | 400 | 45.955 |
| 12:54 ET | 665 | 45.945 |
| 12:56 ET | 500 | 45.93 |
| 12:57 ET | 800 | 45.94 |
| 12:59 ET | 1014 | 45.93 |
| 01:01 ET | 3498 | 46 |
| 01:03 ET | 100 | 45.99 |
| 01:06 ET | 1533 | 45.99 |
| 01:08 ET | 500 | 45.98 |
| 01:10 ET | 685 | 45.98 |
| 01:12 ET | 1442 | 45.94 |
| 01:14 ET | 200 | 45.93 |
| 01:15 ET | 714 | 45.925 |
| 01:17 ET | 450 | 45.9285 |
| 01:19 ET | 510 | 45.915 |
| 01:21 ET | 400 | 45.915 |
| 01:24 ET | 3050 | 46.005 |
| 01:26 ET | 903 | 45.99 |
| 01:28 ET | 100 | 45.95 |
| 01:30 ET | 200 | 46.005 |
| 01:32 ET | 3007 | 45.995 |
| 01:33 ET | 350 | 46 |
| 01:35 ET | 620 | 46.005 |
| 01:37 ET | 9168 | 46.005 |
| 01:39 ET | 701 | 45.97 |
| 01:42 ET | 1720 | 46 |
| 01:44 ET | 2063 | 46 |
| 01:46 ET | 2624 | 45.985 |
| 01:48 ET | 300 | 45.995 |
| 01:50 ET | 1814 | 46 |
| 01:51 ET | 20297 | 46.01 |
| 01:53 ET | 10193 | 46.08 |
| 01:55 ET | 4838 | 46.09 |
| 01:57 ET | 900 | 46.11 |
| 02:00 ET | 1110 | 46.05 |
| 02:02 ET | 200 | 46.085 |
| 02:04 ET | 200 | 46.07 |
| 02:06 ET | 1015 | 46.1017 |
| 02:08 ET | 1588 | 46.01 |
| 02:09 ET | 100 | 46.06 |
| 02:11 ET | 3410 | 46.082 |
| 02:13 ET | 300 | 46.055 |
| 02:15 ET | 2500 | 46.03 |
| 02:18 ET | 600 | 46.045 |
| 02:20 ET | 1000 | 46.005 |
| 02:22 ET | 100 | 46.015 |
| 02:24 ET | 900 | 46.0025 |
| 02:26 ET | 800 | 46.015 |
| 02:27 ET | 3900 | 46.08 |
| 02:29 ET | 535 | 46.06 |
| 02:33 ET | 500 | 46.08 |
| 02:36 ET | 600 | 46.075 |
| 02:40 ET | 200 | 46.075 |
| 02:42 ET | 2633 | 46.085 |
| 02:44 ET | 1038 | 46.055 |
| 02:45 ET | 500 | 46.07 |
| 02:47 ET | 2400 | 46.089 |
| 02:49 ET | 1500 | 46.08 |
| 02:51 ET | 877 | 46.11 |
| 02:54 ET | 500 | 46.095 |
| 02:56 ET | 320 | 46.09 |
| 02:58 ET | 100 | 46.09 |
| 03:00 ET | 1100 | 46.08 |
| 03:02 ET | 567 | 46.08 |
| 03:03 ET | 2929 | 46.11 |
| 03:05 ET | 400 | 46.115 |
| 03:07 ET | 1300 | 46.16 |
| 03:09 ET | 1422 | 46.175 |
| 03:12 ET | 2422 | 46.15 |
| 03:14 ET | 750 | 46.11 |
| 03:16 ET | 2300 | 46.18 |
| 03:18 ET | 1351 | 46.16 |
| 03:20 ET | 900 | 46.21 |
| 03:21 ET | 2067 | 46.26 |
| 03:23 ET | 1000 | 46.295 |
| 03:25 ET | 500 | 46.34 |
| 03:27 ET | 1373 | 46.3 |
| 03:30 ET | 2009 | 46.24 |
| 03:32 ET | 1000 | 46.22 |
| 03:34 ET | 800 | 46.27 |
| 03:36 ET | 1076 | 46.27 |
| 03:38 ET | 3096 | 46.13 |
| 03:39 ET | 900 | 46.18 |
| 03:41 ET | 2500 | 46.225 |
| 03:43 ET | 1402 | 46.23 |
| 03:45 ET | 1202 | 46.215 |
| 03:48 ET | 2290 | 46.24 |
| 03:50 ET | 4968 | 46.13 |
| 03:52 ET | 3656 | 46.16 |
| 03:54 ET | 6611 | 46.09 |
| 03:56 ET | 6076 | 46.14 |
| 03:57 ET | 10233 | 46.09 |
| 03:59 ET | 122488 | 46.09 |
Jun 27, 2024
DJ Ionis Pharmaceuticals Is Maintained at Hold by Stifel, from 8:30AM ET on Thursday Jun 27, 2024 by Dow Jones
8:30AM ET on Thursday Jun 27, 2024 by Dow Jones
Jun 25, 2024
Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed, from 6:55AM ET on Tuesday Jun 25, 2024 by Dow Jones
6:55AM ET on Tuesday Jun 25, 2024 by Dow Jones
Jun 24, 2024
DJ Alnylam Pharmaceuticals' Drug Results Called 'Best Case' Scenario -- Market Talk, from 8:22AM ET on Monday Jun 24, 2024 by Dow Jones
8:22AM ET on Monday Jun 24, 2024 by Dow Jones
Jun 18, 2024
Jun 17, 2024
Ionis to present at TD Cowen Genetic Medicines & RNA Summit, from 4:10PM ET on Monday Jun 17, 2024 by Dow Jones
4:10PM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ionis Pharmaceuticals Inc | 6.7B | -17.3x | --- |
Halozyme Therapeutics Inc | 6.6B | 21.3x | --- |
Tempus AI Inc | 5.1B | -17.4x | --- |
Intra-Cellular Therapies Inc | 7.3B | -60.4x | --- |
Blueprint Medicines Corp | 7.0B | -23.2x | --- |
ACADIA Pharmaceuticals Inc | 2.7B | -1,253.3x | --- |
Company Information
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Contact Information
- Headquarters
- 2855 Gazelle CourtCARLSBAD, CA, United States 92010
- Phone
- 760-931-9200
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Joseph Loscalzo
- Chief Executive Officer, Director
- Brett Monia
- Chief Financial Officer, Executive Vice President - Finance
- Elizabeth Hougen
- Chief Scientific Officer
- C. Frank Bennett
- Executive Vice President, Chief Business Officer
- Joseph Baroldi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.7B |
|---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.40 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -17.3x |
Price/Sales (TTM) | 8.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -48.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
